Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
FDA approves Farxiga for heart failure
Farxiga was shown in a clinical trial to improve survival and reduce the need for hospitalisation in adults with heart failure…
‘Lock Out’ pain through combiflam plus’ newest digital campaign #LockdownWaaliLife
Combiflam’s recent social media campaign takes on a quirky route to highlight the mental agony and physical pain of maintaining…
Regeneron says COVID-19 antibody cocktail may be available by fall
The company is one of the many drugmakers looking to tackle COVID-19, caused by the new coronavirus that has no current approved…
Gilead’s anti-viral remdesivir may be found effective against coronavirus
The company is in discussions with some of the world’s leading chemical and pharmaceutical manufacturing companies about their…
PMBJKs accepting orders on WhatsApp and e-mail to facilitate medicine procurement during lockdown
The novel move is ensuring use of technology for facilitating easier procurement of medicines by the users.
Amidst lockdown,…
Scientists to culture novel coronavirus in human lung epithelial cell
It will enable in vitro testing of potential drugs and vaccines against COVID-19
China’s blockchain-backed recovery from COVID-19 could pave way for efficient disease surveillance…
After the SARS epidemic hit the country, the Chinese Center for Disease Control and Prevention implemented a new nationwide…
Pharma industry to seek permission for use of cartons with pre-printed labels
The government had allowed manufacturers or packers to utilise existing packaging material/wrapper up to September 30, 2020,…
Israel made ‘significant breakthrough’ in developing antibody against coronavirus:…
Defense Minister Bennett visited the labs of the Israel’s Institute for Biological Research (IIBR), supervised by the Prime…
Success of new research projects crucial to contain community spread of COVID-19 in India:…
The main objectives of these projects are to develop solutions to reduce community transmission and identify novel targets with…